Beximco Pharmaceuticals Ltd.
BXP | IL
Overview
Corporate Details
- ISIN(s):
- US0885792061
- LEI:
- 213800IMBBD6TIOQGB56
- Country:
- Bangladesh
- Address:
- N/A
- Website:
- https://www.beximcopharma.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 17:10 |
Report Publication Announcement
Request of Extension to Publish Q1 Results
|
English | 11.2 KB | ||
| 2025-11-04 08:25 |
Regulatory Filings
Change of Name to Beximco Pharmaceuticals PLC.
|
English | 10.8 KB | ||
| 2025-10-27 16:53 |
Report Publication Announcement
Request of Extension to Publish Financial Results
|
English | 11.3 KB |
Automate Your Workflow. Get a real-time feed of all Beximco Pharmaceuticals Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for Beximco Pharmaceuticals Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Beximco Pharmaceuticals Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops therapies for metabolic diseases like obesity by targeting the biology of human aging.
United States of America
BIOA
United States of America
BIOA
Developing safer, conditionally active antibody therapies for solid tumor cancers.
United States of America
BCAB
United States of America
BCAB
Develops and manufactures injectable aesthetic solutions like HA fillers for global markets.
South Korea
489460
South Korea
489460
Developing regenerative cell therapies for cardiovascular and pulmonary diseases.
United States of America
BCDA
United States of America
BCDA
Develops an automated PCR platform for fast molecular diagnostics in oncology & infectious diseases.
Belgium
BCART
Belgium
BCART
Developing 'off-the-shelf' stem cell therapies for diseases in companion animals.
Poland
BCX
Poland
BCX
Develops oral small-molecule drugs for rare diseases like hereditary angioedema.
United States of America
BCRX
United States of America
BCRX
Develops treatments for rare diseases, diabetes, and cancer using proprietary drug delivery tech.
United States of America
BDRX
United States of America
BDRX
A top domestic manufacturer of pharmaceuticals, supplements, and soft gelatin capsules.
Romania
BIO
Romania
BIO
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea
251120
South Korea
251120